| Literature DB >> 35736923 |
Phu Quang Pham1, Vuong Ba Nguyen2, Tai The Pham3, Nhuong Xuan Duong1, Ha Trong Nguyen2, Quang Van Ha2, Thuan Duc Nguyen2, Tuan Minh Hoang1, Dong Tien Dinh1, Quynh Thi Nhu Tran4, Linh Kim Bui5, Thuy Thi Vu6, Manh Van Phan7, Tuan Minh Luong8, Khanh Nguyen9, Dung Anh Vu10, Thao Ngoc Pham11.
Abstract
We investigated changes in some laboratory indices and the liver histology of chronic hepatitis patients who were exposed to dioxin. In 2014, we collected liver biopsy samples for histopathological examination from 33 chronic hepatitis patients living around the Da Nang Airbase, which is a dioxin-contaminated area due to the herbicide spraying in Vietnam. Dioxin exposure was measured by its levels in the blood. METAVIR classification was used to clarify the liver fibrosis stage. Laboratory tests included ten biochemical and six hematological indices that were measured in the blood. A regression linear model and binary logistic regression were used for data analysis. The observed alterations in the liver at the histological level mainly comprised hydropic degenerative hepatocytes, lymphocytes and polynuclear leukocytes surrounding the liver cells and granular and lipoic degeneration. In addition, increased TCDD levels were associated with increasing aminotransferase (AST), alanine aminotransferase, protein and total bilirubin levels and liver fibrosis stage. Similarly, increased TEQ-PCDD/Fs levels were associated with higher levels of AST and protein and liver fibrosis stage. In conclusion, dioxin exposure altered the liver histology and increased some biochemical marker indices and the liver fibrosis stage of chronic hepatitis patients living in dioxin-contaminated areas in Da Nang, Vietnam.Entities:
Keywords: Vietnam; dioxin; histopathological change; liver damage; liver enzyme
Year: 2022 PMID: 35736923 PMCID: PMC9229980 DOI: 10.3390/toxics10060315
Source DB: PubMed Journal: Toxics ISSN: 2305-6304
Figure 1Histopathology of liver tissues under 10× microscope. The METAVIR fibrosis staging system (F0, F1, F2): (A) F0 (the core needle biopsy shows liver tissue with two central veins, including the infiltration of some chronic inflammatory cells, many hepatocytes with hydropic degeneration and a few hepatocytes with fatty degeneration, but there is no appearance of portal zones); (B) F1 (the core needle biopsy shows liver tissue with one portal zone and no central veins, including the infiltration of numerous chronic inflammatory cells, a strong development of connective tissue surround portal zone, the bile duct is expanded and many hepatocytes contain fatty degeneration, but there is no appearance of bridging); (C) F2 (the core needle biopsy shows liver tissue with one or two portal zones and probably one central vein, including the infiltration of numerous chronic inflammatory cells, a strong development of connective tissue surrounding portal zones, many bile ducts are expanded, many hepatocytes contain large fatty degeneration and there is probably the appearance of bridging between central vein and portal zone).
Characteristics of the study subjects.
| Characteristic | Unit | Mean (SD), N [%] | |
|---|---|---|---|
| Subjects | |||
| Age | year | 46.3 (12.1) | |
| Ratio of Male | % male | 16 [48.5%] | |
| Smoking Status | % smoker | 16 [48.5%] | |
| Alcohol Consumption | % drinking alcohol | 0 [0.0%] | |
| Length stayed in dioxin contaminated areas | Year | 26.0 (10.6) | |
| BMI | 21.7 (2.1) | ||
| METAVIR Score | |||
| F0 | % | 9 [17.3%] | |
| F1 | % | 14 [42.4%] | |
| F2 | % | 10 [30.3%] | |
| Dioxin Concentration in Blood | |||
| TCDD | pg/g lipid | 15.7 (3.7) * | |
| TEQ-PCDD/Fs | pg-TEQ/g lipid | 42.5 (2.5) * | |
N, number of subjects; SD, standard deviation; BMI, body mass index; TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin; PCDD/Fs, polychlorinated dibenzo-p-dioxins and polychlorinated dibenzo furans; TEQ, toxic equivalent quantity; *, geometrical mean and geometrical standard.
Associations between TCDD and TEQ-PCDD/Fs concentration and biomarker indices.
| TCDD | TEQ-PCDD/FS | ||||||
|---|---|---|---|---|---|---|---|
| Markers | N | β | 95% CI |
| β | 95% CI |
|
| Aspartate Aminotransferase (AST) | 33 | 0.414 | (0.071, 0.758) | 0.020 | 0.393 | (0.046, 0.741) | 0.028 |
| Alanine Aminotransferase (ALT) | 33 | 0.359 | (0.009, 0.709) | 0.045 | 0.349 | (−0.003, 0.702) | 0.052 |
| Gamma-Glutamyl Transpeptidase (GGT) | 33 | 0.340 | (−0.020, 0.699) | 0.063 | 0.298 | (−0.068, 0.664) | 0.107 |
| Total Bilirubin | 33 | 0.389 | (0.030, 0.748) | 0.035 | 0.283 | (−0.091, 0.656) | 0.133 |
| Glucose | 33 | −0.05 | (−0.417, 0.318) | 0.79 | −0.14 | (−0.502, 0.229) | 0.45 |
| Urea | 33 | 0.031 | (−0.318, 0.381) | 0.855 | −0.013 | (−0.364, 0.337) | 0.938 |
| Creatinin | 33 | −0.011 | (−0.284, 0.262) | 0.933 | 0.062 | (−0.211, 0.334) | 0.648 |
| Protein | 33 | 0.421 | (0.104, 0.738) | 0.011 | 0.351 | (0.021, 0.680) | 0.038 |
| Cholesterone | 33 | 0.029 | (−0.334, 0.392) | 0.871 | 0.006 | (−0.358, 0.370) | 0.974 |
| Triglyceride | 33 | 0.043 | (−0.334, 0.420) | 0.816 | 0.104 | (−0.272, 0.480) | 0.576 |
| Red Blood Cells | 33 | 0.137 | (−0.200, 0.474) | 0.412 | 0.078 | (−0.263, 0.418) | 0.644 |
| Hemoglobin | 33 | 0.003 | (−0.288, 0.294) | 0.985 | −0.024 | (−0.316, 0.267) | 0.866 |
| Leukocytes | 33 | −0.031 | (−0.420, 0.357) | 0.870 | −0.225 | (−0.605, 0.155) | 0.236 |
| Neutrocytes | 33 | −0.201 | (−0.582, 0.181) | 0.291 | −0.240 | (−0.619, 0.139) | 0.205 |
| Lymphocytes | 33 | 0.234 | (−0.146, 0.614) | 0.218 | 0.299 | (−0.075, 0.673) | 0.113 |
| Platelets | 33 | −0.172 | (−0.549, 0.206) | 0.360 | −0.127 | (−0.508, 0.254) | 0.500 |
TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin; PCDD/Fs, polychlorinated dibenzo-p-dioxins and polychlorinated dibenzo furans; TEQ, toxic equivalent quantity; N, number of subjects; β, standardized beta; 95% CI, 95% confidence interval. Confounding factors: gender; age; smoking status.
Histopathological damage among chronic hepatitis patients who were exposed to dioxin.
| Histopathological Damage | Yes | No |
|---|---|---|
| Granular Degeneration | 32 (97.0) | 1 (3.0) |
| Hydropic Degeneration | 33 (100) | 0 (0.0) |
| Lipoic Degeneration | 32 (97.0) | 1 (3.0) |
| Lipogranuloma | 0 (0.0) | 33 (100) |
| Lymphocytes and Polynuclear Leukocytes Surrounding the Liver Cells | 33 (100) | 0 (0.0) |
| Mallory Bodies | 0 (0.0) | 33 (100) |
| Pigmentation | 0 (0.0) | 33 (100) |
| Megamitochondria | 0 (0.0) | 33 (100) |
| Changes in Acidophil Hepatocyte | 4 (12.1) | 29 (87.9) |
| Venous Obstruction | 0 (0.0) | 33 (100) |
N, number of subjects.
Relationships between TCDD and TEQ-PCDD/Fs exposure and positive METAVIR scores (F2).
| OR | SE | 95% CI (Lower, Upper) |
| |
|---|---|---|---|---|
| TCDD | 5.9 | 0.7 | (1.6, 21.4) | 0.007 |
| TEQ-PCDDs/Fs | 3.9 | 0.6 | (1.2, 12.1) | 0.021 |
TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin; TEQ, toxic equivalent quantity; PCDD/Fs, polychlorinated dibenzo-p-dioxins and polychlorinated dibenzo furans; OR, odd ratio; SE, standard error; 95% CI, 95% confidence interval. Covariates: age; gender; smoking status.